We report the case of a newborn boy with multinodular NRAS-and BRAF-mutation negative congenital melanocytic nevi and cerebral lesions compatible with congenital intraparenchymal melanosis. Histopathology from skin lesions showed atypical nodular melanocytic proliferation with marked melanocytic atypia and a high number of mitoses and apoptosis, indicating aggressive proliferation. The child developed several new subcutaneous tumors and multiple internal lesions, which were confirmed to be metastases, and died five months old. This case may represent an infantile melanoma developing from a giant congenital melanocytic nevus, or a congenital melanoma.
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Congenital melanocytic nevi (CMNs) may vary greatly at birth, from single small macules to large nodules with multiple satellite lesions covering most of the body surface with or without additional involvement of the central nervous system.
(1) Although most CMNs do not change significantly, some may develop changes of color or nodules in a short period of time, making
clinical and histological findings difficult to interpret. We present a case that highlights the challenges involved in assessing such patients.
Case report
A 32-year-old pregnant woman was transferred to our hospital following a 3D ultrasound at week 27 of gestation, with findings suggesting a vascular malformation in the fetus. A previous routine pregnancy ultrasound at week 20 was normal. Both parents were healthy and unrelated with no known hereditary diseases, and they had a 3-year old healthy daughter.
A boy, weighing 4 kg with a length of 51cm was delivered by caesarian section at 37
weeks. Apgar scores were 6 and 7 at 1 and 5 minutes, respectively. The boy had a large, multilobular, pigmented lesion covering both the anterior and posterior aspects of the lower body, including buttocks and genital area (Figure 1 ), as well as multiple pigmented macules and nodules on the extremities, head and face. The total body surface area covered by pigmented lesions was approximately 35%. The largest lesion on the lower part of the torso had a partially eroded surface and a spongy, non-pitting consistency, which diminished considerably within two days, and was consequently perceived as declining edema. The placenta had a macroscopic normal appearance, with a size of 17.5x18cm and a net weight of 778 g.
A thoraco-abdominal magnetic resonance imaging scan (MRI) one day after birth showed that the largest skin lesion infiltrated the subcutaneous fat, with no deeper extension or additional abnormalities in the chest, abdomen or extremities (Figure 2a ). There was high signal in T2
Turbo Spin Echo (TSE) Dixon sequence in the dermal layer of the lower torso, corresponding to the largest lesion, compatible with edema. A craniospinal MRI scan showed several foci with high signal in T1 in both parenchyma and cortex of both hemispheres. These results were compatible with intraparenchymal melanosis and confirmed a diagnosis of congenital melanocytic nevus syndrome. (1) The infant was otherwise in good health and seemingly unaffected by the skin and brain lesions.
In total, 14 biopsies were taken for histopathological examination. A diagnosis of metastatic melanoma, primary site unknown, was made. Palliative care was agreed upon, consisting of pain relief and parenteral hydration. The patient died three weeks later.
Discussion
Hypercellularity, atypia and increased mitotic figures are all clear signs of malignancy. However, these were simultaneously found in several nodules from different areas of the skin in the neonatal period. Thus, these were perceived as atypical nodular melanocytic proliferations. There are currently no reliable markers that can discern between proliferative nodules and melanoma in patients with CMN during infancy, although copy number analysis and markers of methylation may be helpful. (5, 6) Tissue and blood samples are currently been analyzed by whole-genome sequencing and array CGH as part of an on-going, multi-patient study on CMN.
A main challenge in this unusual case was the extent and depth of nodular disease at birth, rendering active surgical management unlikely to alter outcome even if a diagnosis of melanoma could have been made. In addition, kinase inhibition treatment was not an option due to the NRAS-and BRAF-negative status of the lesions. Other published cases of CMN syndrome have been shown to be caused by post-zygotic NRAS-mutations in approximately 80%. (7, 8) We did not, however, find any NRAS mutations (codons 12, 13, 61) or BRAF mutations. Checkpoint inhibition therapy was not considered to be an option due to the rapid and fatal course of the case.
The risk of developing melanoma from CMNs varies with congenital phenotype; a recent review and prospective cohort study concludes that the average melanoma incidence for all
CMNs is 1-2%, with wide variation depending on the severity of the congenital phenotype. For large CMNs with satellite lesions, the lifetime risk rises to 10-15%. (9) (10) (11) The strongest risk factor appears to be abnormal MRI screening of the CNS in the first months of life, with a melanoma incidence of 12%. (9, 12, 13) The literature does not support surgery as a prophylactic intervention to avoid malignant transformation. (12, 14) Consequently, management of large CMN and the potential need for 
